Literature DB >> 10954230

Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montelukast.

N Hani, K Hartmann, C Casper, T Peters, L A Schneider, N Hunzelmann, K Scharffetter-Kochanek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10954230     DOI： 10.1080/000155500750043168

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  6 in total

1.  Investigation of patient-specific characteristics associated with treatment outcomes for chronic urticaria.

Authors:  Priyal Amin; Linda Levin; Sarah J Holmes; Jillian Picard; Jonathan A Bernstein
Journal:  J Allergy Clin Immunol Pract       Date:  2015-02-11

Review 2.  Chronic urticaria: aetiology, management and current and future treatment options.

Authors:  Martina M A Kozel; Ruth A Sabroe
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  The employment of leukotriene antagonists in cutaneous diseases belonging to allergological field.

Authors:  Eustachio Nettis; Maddalena D'Erasmo; Elisabetta Di Leo; Gianfranco Calogiuri; Vincenzo Montinaro; Antonio Ferrannini; Angelo Vacca
Journal:  Mediators Inflamm       Date:  2010-09-22       Impact factor: 4.711

4.  Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review.

Authors:  Gabriele Di Lorenzo; Alberto D'Alcamo; Manfredi Rizzo; Maria Stefania Leto-Barone; Claudia Lo Bianco; Vito Ditta; Donatella Politi; Francesco Castello; Ilenia Pepe; Gaetana Di Fede; Giovambattista Rini
Journal:  J Asthma Allergy       Date:  2008-12-09

5.  Review of cold-induced urticaria characteristics, diagnosis and management in a Western Canadian allergy practice.

Authors:  Peter Stepaniuk; Kateryna Vostretsova; Amin Kanani
Journal:  Allergy Asthma Clin Immunol       Date:  2018-12-18       Impact factor: 3.406

6.  Leukotriene Antagonists in Dermatology.

Authors:  Aditya Kumar Bubna
Journal:  Indian J Dermatol       Date:  2021 Sep-Oct       Impact factor: 1.494
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.